Fig. 5From: Establishment and validation of serum lipid-based nomogram for predicting the risk of prostate cancerDecision curve analysis for the prostate cancer risk nomogram. The y-axis measures the net benefit. The thick solid line = net benefit when all patients have no prostate cancer, the thin solid line = net benefit when all patients have prostate cancer, the solid green line = PSA, the solid red line = Model 1, solid blue line = Model 2. A from the training set, B from the validation setBack to article page